Profile | GDS5420 / 236524_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 508.65 | 67 |
GSM1296119 | B_lesional_pre-dose | 234.91 | 55 |
GSM1296076 | C_lesional_pre-dose | 165.12 | 51 |
GSM1296092 | D_lesional_pre-dose | 171.01 | 52 |
GSM1296103 | E_lesional_pre-dose | 566.33 | 70 |
GSM1296078 | F_lesional_pre-dose | 240.87 | 57 |
GSM1296107 | G_lesional_pre-dose | 366.79 | 62 |
GSM1296109 | H_lesional_pre-dose | 254.61 | 55 |
GSM1296080 | I_lesional_pre-dose | 280.2 | 59 |
GSM1296090 | J_lesional_pre-dose | 146.33 | 49 |
GSM1296074 | K_lesional_pre-dose | 101.33 | 44 |
GSM1296111 | L_lesional_pre-dose | 273.02 | 57 |
GSM1296099 | M_lesional_pre-dose | 399.69 | 63 |
GSM1296086 | O_lesional_pre-dose | 191.43 | 53 |
GSM1296117 | P_lesional_pre-dose | 267.51 | 56 |
GSM1296113 | Q_lesional_pre-dose | 315.34 | 59 |
GSM1296096 | R_lesional_pre-dose | 389.43 | 63 |
GSM1296105 | S_lesional_pre-dose | 590.91 | 70 |
GSM1296098 | T_lesional_pre-dose | 726.06 | 74 |
GSM1296101 | U_lesional_pre-dose | 428.82 | 65 |
GSM1296121 | V_lesional_pre-dose | 299.71 | 59 |
GSM1296088 | W_lesional_pre-dose | 247.13 | 56 |
GSM1296082 | X_lesional_pre-dose | 145.84 | 49 |
GSM1296115 | Y_lesional_pre-dose | 315.12 | 60 |
GSM1296084 | Z_lesional_pre-dose | 267.86 | 57 |
GSM1296072 | B_lesional_day8 | 223.56 | 53 |
GSM1296069 | L_lesional_day8 | 342.09 | 60 |
GSM1296071 | P_lesional_day8 | 326.43 | 59 |
GSM1296070 | Y_lesional_day8 | 354.55 | 61 |
GSM1296073 | V_lesional_day8 | 208.94 | 53 |
GSM1296034 | A_lesional_day15 | 807.92 | 75 |
GSM1296041 | G_lesional_day15 | 282.64 | 58 |
GSM1296035 | R_lesional_day15 | 300.55 | 59 |
GSM1296038 | U_lesional_day15 | 433.75 | 65 |
GSM1296047 | B_lesional_day15 | 260.09 | 56 |
GSM1296039 | E_lesional_day15 | 308.3 | 60 |
GSM1296042 | H_lesional_day15 | 317.24 | 59 |
GSM1296043 | L_lesional_day15 | 359.24 | 61 |
GSM1296037 | M_lesional_day15 | 414.37 | 64 |
GSM1296046 | P_lesional_day15 | 315.92 | 59 |
GSM1296044 | Q_lesional_day15 | 315.83 | 59 |
GSM1296045 | Y_lesional_day15 | 273.68 | 56 |
GSM1296025 | C_lesional_day15 | 207.03 | 53 |
GSM1296033 | D_lesional_day15 | 237.93 | 55 |
GSM1296027 | I_lesional_day15 | 157.34 | 50 |
GSM1296032 | J_lesional_day15 | 237.87 | 55 |
GSM1296024 | K_lesional_day15 | 172.69 | 51 |
GSM1296031 | W_lesional_day15 | 314.58 | 59 |
GSM1296028 | X_lesional_day15 | 236.08 | 55 |
GSM1296029 | Z_lesional_day15 | 239.64 | 55 |
GSM1296026 | F_lesional_day15 | 150.09 | 49 |
GSM1296030 | O_lesional_day15 | 137.43 | 49 |
GSM1296040 | S_lesional_day15 | 570.46 | 70 |
GSM1296036 | T_lesional_day15 | 745.88 | 74 |
GSM1296048 | V_lesional_day15 | 255.2 | 56 |
GSM1296059 | A_lesional_day43 | 323.05 | 60 |
GSM1296066 | G_lesional_day43 | 329.36 | 60 |
GSM1296060 | R_lesional_day43 | 406.31 | 64 |
GSM1296063 | U_lesional_day43 | 334.03 | 61 |
GSM1296064 | E_lesional_day43 | 353.95 | 62 |
GSM1296067 | H_lesional_day43 | 276.37 | 56 |
GSM1296062 | M_lesional_day43 | 378.67 | 62 |
GSM1296068 | Q_lesional_day43 | 322.16 | 59 |
GSM1296050 | C_lesional_day43 | 305.18 | 60 |
GSM1296057 | D_lesional_day43 | 246.42 | 56 |
GSM1296052 | I_lesional_day43 | 129.01 | 47 |
GSM1296054 | J_lesional_day43 | 344.41 | 61 |
GSM1296049 | K_lesional_day43 | 387.31 | 64 |
GSM1296055 | W_lesional_day43 | 334.07 | 60 |
GSM1296053 | X_lesional_day43 | 333.1 | 61 |
GSM1296058 | Z_lesional_day43 | 197.65 | 53 |
GSM1296051 | F_lesional_day43 | 257.96 | 58 |
GSM1296056 | O_lesional_day43 | 200.79 | 53 |
GSM1296065 | S_lesional_day43 | 336.7 | 61 |
GSM1296061 | T_lesional_day43 | 623.56 | 71 |
GSM1296095 | A_non-lesional_pre-dose | 352.15 | 62 |
GSM1296120 | B_non-lesional_pre-dose | 333.91 | 60 |
GSM1296077 | C_non-lesional_pre-dose | 130.04 | 46 |
GSM1296093 | D_non-lesional_pre-dose | 525.15 | 68 |
GSM1296104 | E_non-lesional_pre-dose | 383.1 | 63 |
GSM1296079 | F_non-lesional_pre-dose | 277.04 | 58 |
GSM1296108 | G_non-lesional_pre-dose | 364.65 | 62 |
GSM1296110 | H_non-lesional_pre-dose | 334.21 | 60 |
GSM1296081 | I_non-lesional_pre-dose | 300.53 | 60 |
GSM1296091 | J_non-lesional_pre-dose | 186.25 | 52 |
GSM1296075 | K_non-lesional_pre-dose | 81.98 | 39 |
GSM1296112 | L_non-lesional_pre-dose | 353.97 | 61 |
GSM1296100 | M_non-lesional_pre-dose | 428.55 | 64 |
GSM1296087 | O_non-lesional_pre-dose | 167.53 | 51 |
GSM1296118 | P_non-lesional_pre-dose | 347.3 | 60 |
GSM1296114 | Q_non-lesional_pre-dose | 302.86 | 58 |
GSM1296097 | R_non-lesional_pre-dose | 434.13 | 65 |
GSM1296106 | S_non-lesional_pre-dose | 509.53 | 67 |
GSM1296102 | U_non-lesional_pre-dose | 434.62 | 64 |
GSM1296122 | V_non-lesional_pre-dose | 270.4 | 57 |
GSM1296089 | W_non-lesional_pre-dose | 335.89 | 60 |
GSM1296083 | X_non-lesional_pre-dose | 441.79 | 65 |
GSM1296116 | Y_non-lesional_pre-dose | 356.03 | 61 |
GSM1296085 | Z_non-lesional_pre-dose | 243.1 | 56 |